ANA EVERWINE: Open Payments
NPI 1548628274 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 18 payments from 10 companies in 2025. Trend: 2023 $548 · 2024 $178 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $87 |
| Exact Sciences Corporation | 4 | $62 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| ABBVIE INC. | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: Cologuard Collection Kit, JARDIANCE, TRELEGY ELLIPTA, VRAYLAR, INSPIRE, TRINTELLIX, Ozempic, FARXIGA.
Industry payments across TX — which companies pay providers there.
